Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?

The aim of this study was to investigate the effects of administrating Remdesivir at the acute COVID-19 phase on developing post-COVID symptoms in previously hospitalized COVID-19 survivors by controlling factors such as age, sex, body mass index, and vaccination status. A case-control study was per...

Celý popis

Podrobná bibliografie

Hlavní autoři:	César Fernández-de-las-Peñas, Anabel Franco-Moreno, María Ruiz-Ruigómez, Estibaliz Arrieta-Ortubay, Pablo Ryan-Murua, Carlos Lumbreras-Bermejo, Pablo del-Valle-Loarte, Oscar J. Pellicer-Valero, Rocco Giordano, Lars Arendt-Nielsen, Isabel Martín-Garrido, Juan Torres-Macho
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2024-06-01
Edice:	Viruses
Témata:	antiviral remdesivir long-COVID post-COVID-19
On-line přístup:	https://www.mdpi.com/1999-4915/16/6/947
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!